Orgenesis Inc.: Nasdaq/NYSE listing notice — Orgenesis moved to OTC Pink Limited after failing to cure 10-K delinquency

Orgenesis Inc.

OTC Markets notified Orgenesis on June 2, 2025, that its common stock would be moved from OTCQX to Pink Limited effective June 3.
The move was triggered by the company's delinquent filing of its annual 10-K for the period ended December 31, 2024.
Orgenesis failed to remedy the deficiency within the 45-day cure period, leading to the downgrade.
The stock now trades on the OTC Pink tier, which has less stringent listing requirements.

item 3.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

Orgenesis Inc. received a otc delisting notice notice regarding late filing.

Exchange: otc
Notice: delisting notice
Deficiency: late filing

Exact text from the filing

June 2, 2025, the OTC Markets Group (“OTC Markets”) notified Orgenesis Inc. (the “Company”) that it has determined to move the Company’s common stock from OTCQX to the Pink Limited tier effective June 3, 2025. As previously reported, On April 17, 2025, Orgenesis Inc. (the “Company”) received a notice that is delinquent in filing its 10-K for the period ending December 31 st , 2024 and therefore no longer meets the OTCQX Requirements for Continued Qualification as per Section 2.2 (A)(1)(i) of the OTCQX Rules for U.S. Companies: All required annual, quarterly and other interim reports on EDGAR.

View on SEC.gov

5 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001641172-25-014075

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.